NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 20 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,000 | +200.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -75.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2014 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q4 2013 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|